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WW domains are small modules that mediate protein/protein interactions. In this issue of Structure, Arago´n
and colleagues show that a WW domain of YAP can mediate complexes with either the canonical PY motif in
an inhibitory Smad or engage in phosphorylation-dependent complexes with one of the activated Smads.
The propensity of YAP WW to recognize a pSP motif is a surprising find with a number of far-reaching
ramifications.Modular protein domains are basic units
of the canonical code of cellular signaling.
The paradigm-changing discovery of
modular protein domains, exemplified by
the characterization of the Src homology
(SH2) domain as a snippet of a protein,
rather than a large surface that is com-
plementary to the cognate ligand pro-
tein (Pawson, 1988), changed our view
of how protein complexes are formed,
regulated, and elicit discrete signals.
In this issue of Structure, Arago´n et al.
(2012) provide an elegant description of
the versatility of one of the smallest
modular protein domains, known as the
WW domain (Bork and Sudol, 1994). By
studying signaling events orchestrated
by transforming growth factor-b and
bone morphogenic protein pathways,
the authors revealed a surprising plas-
ticity of WW domain-containing proteins
in assembling signaling complexes. Two
modes of functional interaction between
Smads and its WW domain-containing
regulators, including a transcriptional co-
activator, YAP, and E3 ubiquitin ligases,such as Nedd4L and Smurf1/2 were
characterized in detail. The authors used
a fine combination of structural biology
to characterize the protein complexes
at high resolution and molecular analyses
in cell culture models to interrogate
the function of the signaling complexes.
One mode of WW domain-mediated
interactions was shown for the inhibitory
Smad (Smad7) as a constitutive and
phosphorylation-independent event. The
first WW domain of YAP isoform,YAP1-2,
was shown to mediate a complex with
the PY motif, also known as PPxY motif,
of Smad7. The other mode of interac-
tion was shown with Smad1, one of the
receptor regulated Smads, as a phos-
phorylation-dependent and composite
complex in which both WW domains of
YAP were involved in unison, recognizing
two sequence motifs within Smad1 (Ara-
go´n et al., 2011). More precisely, in the
interaction with Smad1, the first WW
domain of YAP was engaged in binding
to the phosphorylated serine-proline
motif (serine 206 in human Smad1). Thesecond WW domain of YAP formed a
canonical complex with the adjacent PY
motif of Smad1. The propensity of YAP
WW1 domain to recognize the pSP motif
was a surprising find (Chen and Sudol,
1995). Interestingly, the authors deter-
mined that the affinity of the YAP-WW1-
WW2 for the composite pSP-PY site of
Smad1 was eight times higher than that
of the YAP-WW1 for Smad7, suggesting
a competitive interaction that is balanced
by high local concentrations of Smad7 in
the cell nucleus.
The plasticity of the first WW domain of
YAP in being able to recognize either
canonical PY motif or the phosphorylated
motif, pSP, is appreciated as a novel
finding with important ramifications.
Before the reports of Arago´n and
colleagues, WW domain interactions
with pSP or pTP motifs were limited to
Pin1 WW domain and to a handful of
WW domains of Pin1-related proteins
(Lu et al., 1999). The unique mode of
recognition of phosphorylated motifs by
Pin1 was reinforced by the structure of2012 Elsevier Ltd All rights reserved 1619
Figure 1. Different Modes by which WW Domains Form Complexes with Cognate Proteins
The WW domain-mediated complexes discussed by Arago´n and colleagues are shown in color. Other
modes by whichWWdomain complexes are formed and regulated (see Sudol, 2010 for details) are shown
in black, white, and gray.
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PreviewsPin1 complex with the phosphorylated
peptide (where the ligand-binding pocket
is not intrinsic to the WW domain alone
but is formed by both), the WW domain
of Pin1, and the enzymatic domain of
iso-prolyl iomerase (Verdecia et al.,
2000). The fact that the WW domain of
so-called Class I WW domains, which
mainly recognize PY motifs, has an ability
to recognize and bind pSP motifs, sug-
gests that other WW domains (circa 100
domains in the human proteome) may
have such a propensity as well. The
second important ramification of the two
reports by Arago´n and colleagues is that
the YAP oncogene is one of the two
main effectors of the newly delineated
and intensely studied Hippo tumor
suppressor pathway (Sudol, 2010). The
other effector is TAZ, an ortholog of
YAP, which has a single WW domain1620 Structure 20, October 10, 2012 ª2012 E(with the exception of fish TAZ). Since
both YAP and TAZ are controlled by
a cassette of upstream serine and threo-
nine kinases such as MST and LATS
kinases, it is likely that new regulatory
complexes of YAP/TAZ with other
proteins exist within the Hippo network
because of the ability of YAP (perhaps
TAZ as well) WW domains to sense
selected pS/TP motifs as phospho-
switches (Sudol and Harvey, 2010).
Arago´n and colleagues also reminded
us that WW domains have the ability to
dimerize as hetero-dimers confirming
previous reports on this feature in the
signaling ability ofWWdomains (reviewed
in Sudol, 2010) (Figure 1).
Coincidentally, the WW domain as
a modular protein domain that interacts
with proline-rich ligands was identified in
the same building at The Rockefellerlsevier Ltd All rights reservedUniversity in New York City where the
SH3 domain and its proline-rich ligand
were characterized by the Hanafusa
and Baltimore laboratories (reviewed in
Sudol, 2011). Curiously, SH3 and WW
domains are functionally related by
their ability to recognize proline-rich or
proline-containing ligands. Acknowledg-
ing the large diversity of canonical and
non-canonical ligands currently known
for SH3 domains (reviewed by Saksela
and Permi, 2012), we are confident that
the actual repertoire of WW domain
ligands and the plasticity by which the
WW module forms complexes with them
is quite vast. For sure, new surprises are
in store!
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